We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Mrs
sharlene
greenwood
sharlene.greenwood@nhs.net
Mrs
sharlene
greenwood
sharlene.greenwood@nhs.net
More information about this study, what is involved and how to take part can be found on the study website.
Renal failure
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
This is a multi-centre single-blind waitlist randomised controlled trial (RCT) that will examine the clinical value and cost-effectiveness of an online physical and emotional wellbeing resource for the improvement of health-related quality of life in people with CKD.
Physical inactivity and poor mental health are very real concerns for people living with kidney disease, and they report multiple symptoms that impact upon the physical component of health-related quality of life (HRQoL). A decrease in the physical component of HRQoL is independently associated with mortality and morbidity. In people living with end stage kidney disease (ESKD), systematic reviews indicate that a range of exercise training interventions improve physical function and alleviate disability symptoms. The physical component of HRQoL can be targeted with interventions to enhance physical activity, however people living with kidney disease are still not routinely offered specialist physical activity or mental health support in the NHS.
Kidney Beam is a new wellbeing digital health intervention platform that was developed, and launched, to help people with kidney disease manage their physical and mental health through the Coronavirus 2019 (COVID-19) pandemic, resulting lockdown and beyond. It involves a digital health intervention platform to support people with health conditions to stay physically active. Patients will have access to live-on demand or recorded physical activity classes that they will use for 12 weeks with 2 sessions per week.
The study aims to recruit 304 patients to participate on the study with over 18 years of age, with any ability, any
kidney condition, and at any stage of kidney disease.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Interventional type: Psychological & Behavioural;Physical;Rehabilitation;
You can take part if:
You may not be able to take part if:
Exclusion Criteria • Weight < 50kg • Self-reported participation in a structured exercise programme or kidney beam digital health intervention platform within previous 3 months • Active infection • Uncontrolled arrhythmias • Unstable angina or heart attack within the 3 months • Persistent uncontrolled hypertension (systolic blood pressure > 180 mm Hg or diastolic blood pressure > 110 mm Hg) • Recent (within the last 3 months) stroke or transient ischaemic attack • Receiving palliative care for advanced terminal cancer • Patients with peripheral vascular or musculoskeletal disease, who the investigator deems unable to carry out a physical activity intervention. • Any other health condition considered by the local Principal Investigator in which exercise therapy will be contraindicated. • Insufficient understanding of the trial Exclusion criteria for COVID substudy: • Weight < 50kg • Self-reported participation in a structured exercise programme or kidney beam digital health intervention platform within previous 3 months • Active infection • Uncontrolled arrhythmias • Unstable angina or heart attack within the 3 months • Persistent uncontrolled hypertension (systolic blood pressure > 180 mm Hg or diastolic blood pressure > 110 mm Hg) • Recent (within the last 3 months) stroke or transient ischaemic attack • Receiving palliative care for advanced terminal cancer • Patients with peripheral vascular or musculoskeletal disease, who the investigator deems unable to carry out a physical activity intervention. • Any other health condition considered by the local Principal Investigator in which exercise therapy will be contraindicated. • Insufficient understanding of the trial
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Mrs
sharlene
greenwood
sharlene.greenwood@nhs.net
Mrs
sharlene
greenwood
sharlene.greenwood@nhs.net
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST and funded by KIDNEY RESEARCH UK .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 48735
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
